Surmodics, Inc. (NASDAQ: SRDX) has a price-to-earnings ratio of 85.88x that is above its average ratio. Additionally, the 36-month beta value for SRDX is 1.04. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 0 rating it as “overweight,” 2 rating it as “hold,” and 0 rating it as “sell.”
The public float for SRDX is 13.63M and currently, short sellers hold a 3.47% ratio of that float. The average trading volume of SRDX on May 02, 2024 was 64.71K shares.
SRDX) stock’s latest price update
Surmodics, Inc. (NASDAQ: SRDX)’s stock price has soared by 29.74 in relation to previous closing price of 25.69. Nevertheless, the company has seen a gain of 27.85% in its stock price over the last five trading days. Zacks Investment Research reported 2024-05-01 that The headline numbers for SurModics (SRDX) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
SRDX’s Market Performance
Surmodics, Inc. (SRDX) has experienced a 27.85% rise in stock performance for the past week, with a 23.58% rise in the past month, and a -5.34% drop in the past quarter. The volatility ratio for the week is 8.13%, and the volatility levels for the past 30 days are at 4.37% for SRDX. The simple moving average for the past 20 days is 24.96% for SRDX’s stock, with a 2.98% simple moving average for the past 200 days.
Analysts’ Opinion of SRDX
Many brokerage firms have already submitted their reports for SRDX stocks, with Needham repeating the rating for SRDX by listing it as a “Buy.” The predicted price for SRDX in the upcoming period, according to Needham is $36 based on the research report published on June 13, 2023 of the previous year 2023.
SRDX Trading at 16.58% from the 50-Day Moving Average
After a stumble in the market that brought SRDX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -15.43% of loss for the given period.
Volatility was left at 4.37%, however, over the last 30 days, the volatility rate increased by 8.13%, as shares surge +23.63% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +5.57% upper at present.
During the last 5 trading sessions, SRDX rose by +27.85%, which changed the moving average for the period of 200-days by +7.24% in comparison to the 20-day moving average, which settled at $26.99. In addition, Surmodics, Inc. saw -8.31% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for SRDX
Current profitability levels for the company are sitting at:
- 0.13 for the present operating margin
- 0.58 for the gross margin
The net margin for Surmodics, Inc. stands at 0.09. The total capital return value is set at 0.12. Equity return is now at value 4.81, with 3.15 for asset returns.
Based on Surmodics, Inc. (SRDX), the company’s capital structure generated 0.19 points at debt to capital in total, while cash flow to debt ratio is standing at 0.62. The debt to equity ratio resting at 0.24. The interest coverage ratio of the stock is 10.76.
Currently, EBITDA for the company is 14.58 million with net debt to EBITDA at -0.14. When we switch over and look at the enterprise to sales, we see a ratio of 3.29. The receivables turnover for the company is 11.61for trailing twelve months and the total asset turnover is 0.78. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.84.
Conclusion
In conclusion, Surmodics, Inc. (SRDX) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
